This pattern of genes simultaneously methylated, known as the CpG island methylator phenotype (CIMP), suggests that methylation could serve as a new biomarker for predicting risk in ETV6/RUNX1-postive ALL [44]. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.